WANBURY
Back to Balance Sheet
|
WANBURY Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Deferred Tax Assets / Liabilities | ₹-5.50 Cr | ₹-5.50 Cr | ₹-5.63 Cr | ₹-5.63 Cr | ₹-3.36 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of WANBURY ?
Year | Deferred Tax Assets / Liabilities |
---|---|
Mar2024 | ₹-5.50 Cr |
Mar2023 | ₹-5.50 Cr |
Mar2022 | ₹-5.63 Cr |
Mar2021 | ₹-5.63 Cr |
Mar2020 | ₹-3.36 Cr |
How is Deferred Tax Assets / Liabilities of WANBURY Trending?
Years | Deferred Tax Assets / Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹-5.50 Cr | Negative | |
Mar2023 | ₹-5.50 Cr | Negative | |
Mar2022 | ₹-5.63 Cr | Negative | |
Mar2021 | ₹-5.63 Cr | Negative | |
Mar2020 | ₹-3.36 Cr | - |
Compare Deferred Tax Assets / Liabilities of peers of WANBURY
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
WANBURY | ₹826.4 Cr | -13.1% | -17.9% | 103.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹438,143.0 Cr | -1.2% | 0.9% | 41.4% | Stock Analytics | |
DIVIS LABORATORIES | ₹153,076.0 Cr | -3.7% | -1.8% | 46.1% | Stock Analytics | |
CIPLA | ₹118,723.0 Cr | -1.5% | 2.2% | 16.2% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹112,998.0 Cr | 1.4% | 10.6% | 17.2% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹101,569.0 Cr | 3.5% | 3.6% | 37.4% | Stock Analytics |
WANBURY Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
WANBURY | -13.1% |
-17.9% |
103.4% |
SENSEX | -2.9% |
-4.8% |
8% |
You may also like the below Video Courses